|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
1998-8-14
|
|
pubmed:abstractText |
Somatostatin receptor scintigraphy (SRS) and octreotide therapy have both changed the management of gastroenteropancreatic endocrine tumours, but very few data are available on the use of SRS and octreotide to visualise and treat somatostatinomas.
|
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/9691916-1658515,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9691916-1969977,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9691916-2900198,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9691916-2906126,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9691916-6132927,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9691916-7562050,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9691916-8095268,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9691916-8132773,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9691916-8566856,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9691916-8661825,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9691916-8675099,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9691916-9142897
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
0017-5749
|
|
pubmed:author |
pubmed-author:AngelettiSS,
pubmed-author:AnnibaleBB,
pubmed-author:BassoNN,
pubmed-author:BordiCC,
pubmed-author:CorletoV DVD,
pubmed-author:Delle FaveGG,
pubmed-author:MarignaniMM,
pubmed-author:MorettiAA,
pubmed-author:SchillaciOO,
pubmed-author:ScopinaroFF,
pubmed-author:SilecchiaGG
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
42
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
792-4
|
|
pubmed:dateRevised |
2009-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:9691916-Aged,
pubmed-meshheading:9691916-Antineoplastic Agents, Hormonal,
pubmed-meshheading:9691916-Female,
pubmed-meshheading:9691916-Humans,
pubmed-meshheading:9691916-Liver Neoplasms,
pubmed-meshheading:9691916-Male,
pubmed-meshheading:9691916-Middle Aged,
pubmed-meshheading:9691916-Octreotide,
pubmed-meshheading:9691916-Pancreatic Neoplasms,
pubmed-meshheading:9691916-Pentetic Acid,
pubmed-meshheading:9691916-Radiopharmaceuticals,
pubmed-meshheading:9691916-Receptors, Somatostatin,
pubmed-meshheading:9691916-Somatostatin,
pubmed-meshheading:9691916-Somatostatinoma
|
|
pubmed:year |
1998
|
|
pubmed:articleTitle |
Use of the somatostatin analogue octreotide to localise and manage somatostatin-producing tumours.
|
|
pubmed:affiliation |
Department of Gastroenterology, University La Sapienza, Rome, Italy.
|
|
pubmed:publicationType |
Journal Article,
Case Reports,
Research Support, Non-U.S. Gov't
|
